Congenital Hypothyroidism: A simple newborn test can prevent lifelong intellectual disability

New Delhi: On the occasion of Rare Disease Day (February 28), healthcare experts are highlighting the urgent need for early detection of Congenital Hypothyroidism (CH), a condition present at birth in which a baby’s thyroid gland does not produce enough thyroid hormone. Affecting nearly 1 in 1,000 newborns in India, CH impacts an estimated 10,000 babies each year — nearly 27 every day.

Early diagnosis remains the key to preventing lifelong intellectual disability.

Dr. R. Kishore Kumar, President – National Neonatology Forum of Karnataka (2025–27) and Founder Chairman & Neonatologist, Cloudnine Group of Hospitals, stresses that early diagnosis is crucial. “If detected and treated within the first two weeks of life, children can achieve normal intelligence and physical development. Delayed treatment, however, can reduce IQ by 30–50 points,” he says.

Thyroid hormone (thyroxine or T4) is essential for brain development, growth, bone maturation, muscle strength, and metabolism, especially in the first few weeks of life. Without adequate levels during this critical period, irreversible brain damage can occur. A major challenge is that most affected babies appear completely healthy at birth, and most cases occur randomly without inheritance., since most babies have no identifiable risk factors, universal newborn screening is strongly recommended over selective testing.

The most critical detection window is the newborn period (0–28 days), particularly the first two weeks when brain development is rapid. A simple heel-prick test conducted between 48–72 hours after birth measures Thyroid Stimulating Hormone (TSH) levels. If abnormal, confirmatory blood tests establish the diagnosis. “Mandatory newborn screening in the first few days of life is non-negotiable. Waiting for symptoms defeats prevention,” Dr. Kumar emphasizes.

Early signs are subtle and may appear weeks later, including excessive sleepiness, poor feeding, constipation, prolonged jaundice, hoarse cry, puffy face, or dry skin. By the time symptoms are evident, brain development may already be compromised, making screening the only reliable preventive strategy.

Treatment involves daily oral thyroid hormone replacement, which is safe, affordable, and highly effective. When started within 14 days of life and monitored regularly, children can achieve normal growth and cognitive outcomes. While many children require lifelong therapy, some may be reassessed around three years of age to determine if treatment can be discontinued.

Most cases cannot be entirely prevented, but risk can be reduced by screening and managing maternal thyroid disorders, ensuring adequate iodine intake, attending regular antenatal check-ups, avoiding self-medication with thyroid supplements, and planning newborn screening in advance.

Congenital Hypothyroidism remains one of the most preventable causes of intellectual disability in children. With early testing, diagnosis is simple, treatment is affordable, and outcomes are excellent. Without it, children may face lifelong intellectual and growth challenges. “A baby with Congenital Hypothyroidism may look perfectly normal at birth. A simple heel-prick test can protect the child’s brain for life,” concludes Dr. Kumar.